For Research Use Only · Not For Human or Veterinary Use · UK Research Compounds

RESEARCH USE ONLY · Not for human or veterinary useTracked UK delivery | Customer support
Premium Research Peptide

GLP2-T 60MG

£149.00 GBP
● In stock · Ready to dispatch

GIP/GLP-1 dual-agonist research peptide, extra-high concentration.

Orders dispatch after payment confirmation. Tracked UK delivery on eligible catalogue items.
Search the COA library

GIP/GLP-1 dual-agonist research peptide, extra-high concentration.

UK Dispatch
Order Processing
Tracked Delivery
Expert Support
Need wholesale research pricing?Volume options for qualified laboratories and research organizations.View wholesale options ↗
For Research Use Only (RUO). This product is supplied exclusively for in vitro laboratory research. It is not licensed for human or veterinary use, is not a medicine or medicinal product, and must not be administered to humans or animals. By purchasing, you confirm that you are a qualified researcher and will handle the material in accordance with applicable UK legislation and your institution’s health and safety requirements. EVLV UK accepts no liability for misuse.
Ask a Lab Specialist →
GLP2-T 60MG£149.00 GBP
Product information

Product description

GLP2-T 60mg vial supplied for laboratory analytical research. 99.29% purity verified by independent third-party testing.

EVLV fulfills research products from the United States and publishes product-specific batch documentation when a matching laboratory report is available. Testing methods and results are specific to the product and batch identified in each report.

This product is supplied in the format shown on this page: lyophilized powder.

For laboratory research use only. Not for human or veterinary use.

At a glance

Research specifications

Product
GLP2-T 60MG
SKU
TIR60
Purity
99.29%
Form
Lyophilized powder
CAS number
2023788-19-2
Verified content
60.0 mg

Compound research context

Evaluate GLP2-T 60MG beyond the label.

The catalogue CAS reference for Tirzepatide is 2023788-19-2. As a tirzepatide peptide research compound, shared metabolic-research terminology does not make tirzepatide interchangeable with another GLP research class, strength, or lot.

Open the complete Tirzepatide research hub

Classification

GIP and GLP-1 receptor agonist research compound

Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.

Analytical review

Match product, strength, and lot

Confirm the tirzepatide identity and labeled quantity, then match the sample or lot identifier, issuing laboratory, methods, and analysis date. A result for one strength should not be generalized to another.

Product-specific questions

What is tirzepatide peptide in research contexts?

Tirzepatide is a synthetic peptide studied as a dual GIP and GLP-1 receptor agonist in laboratory research. EVLV supplies tirzepatide peptide products strictly for qualified laboratory and analytical research, not for human use.

What tirzepatide peptide strengths does EVLV list?

EVLV lists tirzepatide peptide research products at 10mg, 15mg, 30mg, and 60mg under the GLP2-T catalogue class. Current availability and COA status appear on this page's product grid.

Can Tirzepatide and Semaglutide reports be used interchangeably?

No. They are chemically distinct compounds and require product-specific analytical documentation.